Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury

Background: Postnatal insulin-like growth factor-1 (IGF-1) replacement with recombinant human (rh)IGF-1 and IGF binding protein-3 (rhIGF-1/rhIGFBP-3) is being studied as a potential treatment to reduce comorbidities of prematurity. We have recently reported on a phase II, multicenter, randomized, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Horsch, Sandra, Parodi, Alessandro, Hallberg, Boubou, Malova, Mariya, Björkman-Burtscher, Isabella M., Hansen-Pupp, Ingrid, Marlow, Neil, Beardsall, Kathryn, Dunger, David, van Weissenbruch, Mirjam, Smith, Lois E. H., Hamdani, Mohamed, Mangili, Alexandra, Barton, Norman, Ramenghi, Luca A., Hellström, Ann, Ley, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581737/
https://www.ncbi.nlm.nih.gov/pubmed/33163463
http://dx.doi.org/10.3389/fped.2020.517207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581737/
https://www.ncbi.nlm.nih.gov/pubmed/33163463
http://dx.doi.org/10.3389/fped.2020.517207

Ejemplares similares